Presentation is loading. Please wait.

Presentation is loading. Please wait.

Distribution of unilaterally discarded kidneys by discard category and KDRI (n=7625 kidneys), 2000–2015. Distribution of unilaterally discarded kidneys.

Published byAlois Pokorný Modified over 5 years ago

Similar presentations

Presentation on theme: "Distribution of unilaterally discarded kidneys by discard category and KDRI (n=7625 kidneys), 2000–2015. Distribution of unilaterally discarded kidneys."— Presentation transcript:

1 Distribution of unilaterally discarded kidneys by discard category and KDRI (n=7625 kidneys), 2000–2015. Distribution of unilaterally discarded kidneys by discard category and KDRI(n=7625 kidneys), 2000–2015. Organ damage and anatomical abnormalities were the most frequent reasons for discard among low-KDRI (i.e., high quality) kideys, but accounted for a decreasing fraction of discards as KDRI increased. Biopsy findings, poor function, and inability to locate a recipient accounted for an increasing fraction of discards as KDRI increased. IQR, interquartile range; KDRI, Kidney Donor Risk Index. Syed Ali Husain et al. CJASN 2018;13: ©2018 by American Society of Nephrology

Download ppt "Distribution of unilaterally discarded kidneys by discard category and KDRI (n=7625 kidneys), 2000–2015. Distribution of unilaterally discarded kidneys."

Similar presentations

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.

Among Medicare beneficiaries >65 years old with a index hospitalization at the time of dialysis initiation, use of post-acute SNF care was common. Among.
Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.

Positive interactions between the basic and translational research, clinical research, patient care, and training components of an academic dialysis access.
Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.

Probability of cumulative incidence of ESRD, disease-related death, or death from other cause for the entire cohort. Probability of cumulative incidence.
The proportion of DCD donor kidneys discarded was correlated with the proportion of NBD donor kidneys discarded within DSAs (Pearson correlation coefficient.

The proportion of DCD donor kidneys discarded was correlated with the proportion of NBD donor kidneys discarded within DSAs (Pearson correlation coefficient.
The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.

The incidence of all cause graft failure, and death with a functioning graft was higher in patients who received a DCD donor transplant with total donor.
Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.

Patterns of mortal risk among eKt/V quintiles in the HEMO study for (A) 1 yr of follow-up and (B) after 1 yr. Patterns of mortal risk among eKt/V quintiles.
End-stage renal disease in living kidney donors

End-stage renal disease in living kidney donors
Conceptual model of the natural history of diabetic kidney disease.

Conceptual model of the natural history of diabetic kidney disease.
Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.

Parathyroid hormone (PTH) levels by Dialysis Outcomes and Practice Patterns Study (DOPPS) phase and selected patient characteristics. Parathyroid hormone.
Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.

Patient disposition. Patient disposition. AE, adverse event. *One patient died during the follow-up period. ^Four of the 12 discontinuations of treatment.
Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.

Three-year cumulative incidence of a gout diagnosis presented by level of kidney function and sex. Three-year cumulative incidence of a gout diagnosis.
PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:

PTA for AUC/MIC ratio ≥800 for each 48-hour AUC: AUC0 to 48 (A), AUC48 to 96 (B), and AUC96 to 144 (C). PTA for AUC/MIC ratio ≥800 for each 48-hour AUC:
Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.

Thirty-day survival curves for the rapid versus slow correction rate groups are not significantly different. Thirty-day survival curves for the rapid versus.
Conceptual model of the course of chronic kidney disease (CKD).

Conceptual model of the course of chronic kidney disease (CKD).
Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.

Representative transaxial thin computed tomography (CT) sections at mid, mid-low, and low levels of the heart from a control subject (left) showing normal.
Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.

Seven-year cumulative incidence of ESRD according to baseline creatinine clearance (Ccr) and result of urine test for proteinuria (19). Seven-year cumulative.
Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)

Adjusted means (±SD) of eGFR in relation to the histologic severity of nonalcoholic steatohepatitis (i.e., NASH/fibrosis stage increasing from 0 to 3)
Distribution of podocyte gene mutations in patients with genetic congenital nephrotic syndrome (CNS) and steroid–resistant nephrotic syndrome (SRNS). Distribution.

Distribution of podocyte gene mutations in patients with genetic congenital nephrotic syndrome (CNS) and steroid–resistant nephrotic syndrome (SRNS). Distribution.
Elevated levels of both myeloperoxidase (MPO) and oxidative α1-antitrypsin (oxAT) are associated with high high-sensitivity C-reactive protein (hsCRP)

Elevated levels of both myeloperoxidase (MPO) and oxidative α1-antitrypsin (oxAT) are associated with high high-sensitivity C-reactive protein (hsCRP)
Correlation between the difference in overnight pKt/V (A) or pCrCl (B) and the change in AHI following conversion from NPD to CAPD. pKt/V, peritoneal Kt/V;

Correlation between the difference in overnight pKt/V (A) or pCrCl (B) and the change in AHI following conversion from NPD to CAPD. pKt/V, peritoneal Kt/V;

Similar presentations

Ads by Google